Carcinogenesis explained within the context of a theory of organisms

Progress in Biophysics and Molecular Biology

Volumn 122, Issue 1, 2016, Pages 70-76

  Sonnenschein, Carlos ^a,b,c   Soto, Ana M ^c,d  

^a ECOLE NORMALE SUPÉRIEURE   (France)

^b Institut d Etudes Avancées de Nantes   (France)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

Closure; Default state; Organicism; Stroma epithelium interactions; Tissue organization field theory

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CARCINOGENESIS; CHEMICALLY INDUCED; CLASSIFICATION; HUMAN; NEOPLASM; PATHOLOGY;

ANIMALS; CARCINOGENESIS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 84994159000     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2016.07.004     Document Type: Review

References (53)

1. Baker, S.G., A cancer theory kerfuffle can lead to new lines of research. J. Natl. Cancer Inst., 107, 2015 dju405.
2. Barcellos-Hoff, M.H., Ravani, S.A., Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60 (2000), 1254–1260.
3. Barclay, W.W., Woodruff, R.D., Hall, M.C., Cramer, S.D., A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 146 (2005), 13–18.
4. Bischoff, F., Bryson, G., Carcinogenesis through solid state surfaces. Prog. Exp. Tumor Exp. Tumor Res. 5 (1964), 85–133.
5. Booth, B.W., Boulanger, C.A., Anderson, L.H., Smith, G.H., The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells. Oncogene 30 (2011), 679–689.
6. Boveri, T., Zur Frage der Entstehung Maligner Tumoren. 1914, Fischer, Jena.
7. Boveri, T., The Origin of Malignant Tumors. 1929, Williams & Wilkins, Baltimore, MD.
8. Brodeur, G.M., Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3 (2003), 203–216.
9. Bussard, K.M., Boulanger, C.A., Booth, B.W., Bruno, R.D., Smith, G.H., Reprogramming human cancer cells in the mouse mammary gland. Cancer Res. 70 (2010), 6336–6343.
10. Debruyne, F., Hormonal therapy of prostate cancer. Seminars Urology Oncol. 3:Suppl. 1 (2002), 4–9.
11. Gilbert, S.F., Developmental Biology, vol. 10, 2013, Sinauer Associates, Inc., Sunderland http://10e.devbio.com/article.php?id=23&search=genetics.
12. Gilbert, S.F., Sarkar, S., Embracing complexity: organicism for the 21st century. Dev. Dyn. 219 (2000), 1–9.
13. Haas, D., Ablin, A.R., Miller, C., Zoger, S., Matthay, K.K., Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 62 (1988), 818–825.
14. Hanahan, D., Rethinking the war on cancer. Lancet 383 (2014), 558–563.
15. Huggins, C., Endocrine-induced regression of cancers. Science 156 (1967), 1050–1054.
16. Illmensee, K., Mintz, B., Totipotency and normal differentiation of single teratocarcinoma cell cloned by injection into blastocysts. Proc. Natl. Acad. Sci. U. S. A. 73 (1976), 549–553.
17. Jordan, V.C., Lewis-Wambi, J.S., Patel, R.R., Kim, H., Ariazi, E.A., New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast 3 (2009), S10–S17.
18. Kasemeier-Kulesa, J.C., Teddy, J.M., Postovit, L.M., Seftor, E.A., Seftor, R.E., Hendrix, M.J., Kulesa, P.M., Reprogramming multipotent tumor cells with the embryonic neural crest microenvironment. Dev. Dyn. 237 (2008), 2657–2666.
19. Lehtonen, E., Saxén, L., Cytodifferentiation vs. organogenesis in kidney development. Prog. Clin. Biol. Res. 217A (1986), 411–418.
20. Longo, G., Montévil, M., Sonnenschein, C., Soto, A.M., In search of principles for a theory of organisms. J. Biosci. 40 (2015), 955–968.
21. Longo, G., Soto, A.M., Why do we need theories?. Prog. Biophys. Mol. Biol. 122:1 (2016), 4–10.
22. Maffini, M.V., Calabro, J.M., Soto, A.M., Sonnenschein, C., Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am. J. Pathol. 167 (2005), 1405–1410.
23. Maffini, M.V., Soto, A.M., Calabro, J.M., Ucci, A.A., Sonnenschein, C., The stroma as a crucial target in rat mammary gland carcinogenesis. J. Cell Sci. 117 (2004), 1495–1502.
24. McCullough, A.R., Coleman, W.B., Smith, G.J., Grisham, J.W., Age-dependent induction of hepatic tumor regression by the tissue microenvironment after transplantation of neoplastically transformed rat liver epithelial cells into the liver. Cancer Res. 57 (1997), 1807–1873.
25. Mintz, B., Ilmensee, K., Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 72 (1975), 3585–3589.
26. Montévil, M., Mossio, M., Pocheville, A., Longo, G., Theoretical principles for biology: Variation. Prog. Biophys. Mol. Biol. 122 (2016), 36–50.
27. Montévil, M., Speroni, L., Sonnenschein, C., Soto, A.M., Modeling mammary organogenesis from biological first principles: cells and their physical constraints. Prog. Biophys. Mol. Biol. 122 (2016), 58–69.
28. Moss, L., What Genes Can't Do. 2003, MIT Press, Cambridge, MA.
29. Mossio, M., Montévil, M., Longo, G., Theoretical principles for biology: organization. Prog. Biophys. Mol. Biol. 122 (2016), 24–35.
30. Needham, J., New advances in chemistry and biology of organized growth. Proc. R. Soc. B 29 (1936), 1577–1626.
31. Nowell, P.C., The clonal evolution of tumor cell populations. Science 194 (1976), 123–128.
32. Paszek, M.J., Zahir, N., Johnson, K.R., Lakins, J.N., Rozenberg, G.I., Gefen, A., Reinhart-King, C.A., Margulies, S.S., Dembo, M., Boettiger, D., Hammer, D.A., Weaver, V.M., Tensional homeostasis and the malignant phenotype. Cancer Cell 8 (2005), 241–254.
33. Paulose, T., Speroni, L., Sonnenschein, C., Soto, A.M., Estrogens in the wrong place at the wrong time: fetal BPA exposure and mammary cancer. Reprod. Toxicol. 54 (2015), 58–65.
34. Pierce, G.B., Shikes, R., Fink, L.M., Cancer: a Problem of Developmental Biology. 1978, Prentice-Hall, Englewoods Cliffs, NJ.
35. Shyer, A.E., Tallinen, T., Nerukar, N.L., Wei, Z., Gil, E.S., Kaplan, D.L., Tabin, C.J., Mahadevan, L., Villification: how the gut gets its villi. Science 342 (2013), 212–218.
36. Sirbasku, D.A., Moreno-Cuevas, J.E., Estrogen mitogenic action. II. Negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications. In Vitro Cell. Dev. Biol 36 (2000), 428–446.
37. Smithers, D.W., Cancer: an attack of cytologism. Lancet, 1962, 493–499.
38. Sonnenschein, C., Davis, B., Soto, A.M., A novel pathogenic classification of cancers. Cancer Cell Int. 14 (2014), 113–117.
39. Sonnenschein, C., Soto, A.M., The Society of Cells: Cancer and Control of Cell Proliferation. 1999, Springer Verlag, New York.
40. Sonnenschein, C., Soto, A.M., Theories of carcinogenesis: an emerging perspective. Seminars Cancer Biol. 18 (2008), 372–377.
41. Sonnenschein, C., Soto, A.M., The death of the cancer cell. Cancer Res. 71 (2011), 4334–4337.
42. Sonnenschein, C., Soto, A.M., The aging of the 2000 and 2011 hallmarks of cancer reviews: a critique. J. Biosci. 38 (2013), 651–663.
43. Sonnenschein, C., Soto, A.M., Cancer metastasis: so close and so far. J. Natl. Cancer Inst., 107, 2015.
44. Soto, A.M., Sonnenschein, C., Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. Biochem. Biophys. Res. Commun. 122 (1984), 1097–1103.
45. Soto, A.M., Sonnenschein, C., Environmental causes of cancer: endocrine disruptors as carcinogens. Nat. Rev. Endocrinol. 6 (2010), 363–370.
46. Soto, A.M., Sonnenschein, C., The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. BioEssays 33 (2011), 332–340.
47. Soto, A.M., Longo, G., Montévil, M., Sonnenschein, C., The biological default state of cell proliferation with variation and motility, a fundamental principle for a theory of organisms. Prog. Biophys. Mol. Biol. 122 (2016), 16–23.
48. Stewart, T.A., Mintz, B., Successful generations of mice produced from an established culture line of euploid teratocarcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 78 (1981), 6314–6318.
49. Triolo, V.A., Nineteenth century foundations of cancer research origins of experimental research. Cancer Res. 24 (1964), 4–27.
50. Waddington, C.H., Cancer and the theory of organizers. Nature 135 (1935), 606–608.
51. Weinberg, R.A., Coming full circle-from endless complexity to simplicity and back again. Cell 157 (2014), 267–271.
52. Wray, J., Kalkan, T., Smith, A.G., The ground state of pluripotency. Biochem. Soc. Trans. 38 (2010), 1027–1032.
53. Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., Smith, A., The ground state of embryonic stem cell self-renewal. Nature 453 (2008), 519–523.